Signal Advisors Wealth LLC Increases Holdings in HCA Healthcare, Inc. $HCA

Posted by Francis Steltz on Jun 24th, 2026

Signal Advisors Wealth LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 364.0% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 3,605 shares of the company’s stock after buying an additional 2,828 shares during the quarter. Signal Advisors Wealth LLC’s holdings in HCA Healthcare were worth $1,706,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. State Street Corp raised its holdings in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after purchasing an additional 76,039 shares in the last quarter. Capital World Investors raised its stake in HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after buying an additional 40,086 shares in the last quarter. Geode Capital Management LLC raised its position in shares of HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares in the last quarter. Norges Bank bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership raised its holdings in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reduced their target price on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Barclays dropped their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Oppenheimer lowered their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Finally, Robert W. Baird reduced their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $503.00.

Check Out Our Latest Research Report on HCA Healthcare

HCA Healthcare Trading Up 2.9%

HCA stock opened at $387.82 on Wednesday. The stock has a market capitalization of $86.03 billion, a PE ratio of 13.34, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The stock’s 50 day simple moving average is $414.91 and its 200 day simple moving average is $467.24. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the business earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.